Skip to content

Press release -

Chr. Hansen wins Dairy Innovation Award

Chr. Hansen Australia receives the 2008 Victorian Dairy Innovation Award for its cheese enzyme YieldMAX ™ PL.

The presentation took place at this year’s Dairy Industry Association of Australia state conference held in Melbourne and stresses Chr. Hansen’s image as the leading supplier of innovative ingredients to the dairy industry.

YieldMAX PLTM was one of the first new products from the strategic alliance with Novozymes entered into a few years ago. The cheese enzyme has given a significant increase in cheese yield in production of Pasta Filata type cheeses, which has also been noted in Australia.

Attractive for customers


“We conducted a series of large scale trials in various mozzarella recipes and yields were compared to control days. Yield increases in the region of 1.5 – 3.0% were seen, dependent on recipe, which made the longer term use of YieldMAX ™ attractive for our customer. Cheeses were then assessed at grading for their functional properties to ensure these still matched the specifications as defined by our customer’s customers,” explains Carlo Mason, Dairy Business Manager, Chr. Hansen Australia.

Other Australian and New Zealand dairy customers are continuing to trial YieldMAX ™.

“We are confident that the award, which we are proud to receive, will generate even more interest in YieldMAX ™. And with the continued technical support from our dairy team, more customers will benefit from the improved yields in their cheese make,” concludes Mr Mason.

The Victorian Innovation Award

The Victorian Innovation Award is held annually to encourage and recognise significant breakthroughs in new products and processes with potential or actual application for the dairy industry.

Entries for the Innovation Award come from the fields of production, marketing, packaging, computing, management skills, environmental control, education and training, health and safety.

Topics


Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark